Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?

被引：1
|
作者：
Singh, Jasvinder A. [1 ,2 ,3 ]
机构：
[1] Birmingham VA Med Ctr, Birmingham, AL USA
[2] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Publ Hlth, Div Epidemiol, Birmingham, AL 35294 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷 / 05期
关键词：
PREVALENCE; HYPERURICEMIA; CARE;
D O I：
10.1136/annrheumdis-2016-210519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] TREATMENT OF GOUT - ALLOPURINOL THERAPY IN 100 PATIENTS DURING 8 YEARS
    RIVELIS, L
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1975, 4 : 156 - 156
  • [32] INDICATIONS FOR USE OF ALLOPURINOL IN TREATMENT OF GOUT AND HYPERURICEMIA
    KLINENBE.JR
    CLYMAN, BB
    PEARSON, CM
    ANNALS OF INTERNAL MEDICINE, 1967, 66 (05) : 1059 - +
  • [33] ALLOPURINOL TREATMENT AND RENAL-FUNCTION IN GOUT
    GIBSON, T
    SIMMONDS, HA
    POTTER, C
    ROGERS, V
    ANNALS OF THE RHEUMATIC DISEASES, 1980, 39 (02) : 188 - 189
  • [34] TREATMENT OF GOUT WITH ALLOPURINOL - A STUDY OF 106 CASES
    DELBARRE, F
    AMOR, B
    AUSCHER, C
    DEGERY, A
    ANNALS OF THE RHEUMATIC DISEASES, 1966, 25 (6S) : 627 - &
  • [35] The efficacy of febuxostat and allopurinol in the treatment of gout with hyperuricemia
    Wang, Sufang
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 31 (04) : 1623 - 1627
  • [36] A COMPARISON OF AZAPROPAZONE AND ALLOPURINOL IN THE TREATMENT OF CHRONIC GOUT
    DAYMOND, TJ
    LAWS, D
    TEMPLETON, JS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (01) : P157 - P157
  • [37] Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy
    M. Ruggeri
    M. Basile
    C. Drago
    F. R. Rolli
    A. Cicchetti
    PharmacoEconomics, 2018, 36 : 625 - 636
  • [38] Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy
    Ruggeri, M.
    Basile, M.
    Drago, C.
    Rolli, F. R.
    Cicchetti, A.
    PHARMACOECONOMICS, 2018, 36 (05) : 625 - 636
  • [39] LESINURAD, A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN COMBINATION WITH ALLOPURINOL: RESULTS FROM A PHASE III STUDY IN GOUT PATIENTS HAVING AN INADEQUATE RESPONSE TO STANDARD OF CARE (CLEAR 2)
    Bardin, T.
    Keenan, R.
    Khanna, P.
    Kopicko, J.
    Fung, M.
    Bhakta, N.
    Adler, S.
    Storgard, C.
    Baumgartner, S.
    So, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 545 - 545
  • [40] LESINURAD, A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN COMBINATION WITH ALLOPURINOL: RESULTS FROM A PHASE III STUDY IN GOUT PATIENTS HAVING AN INADEQUATE RESPONSE TO STANDARD OF CARE (CLEAR 1)
    Saag, K.
    Fitz-Patrick, D.
    Kopicko, J.
    Fung, M.
    Bhakta, N.
    Adler, S.
    Storgard, C.
    Baumgartner, S.
    Becker, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 540 - 540
12345